GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
A8548 Fingolimod (FTY720)Target: S1P receptorsSummary: S1P receptors agonist
-
B3225 BAF312 (Siponimod)1 CitationTarget: S1P receptorsSummary: S1P agonist,potent and selective
-
B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: Sphingosine kinase(SK) inhibitor
-
A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1 inhibitor,cell-permeate,potent and selective